← Back to Procter & Gamble Health Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

PGHLPharmaceuticals

Procter & Gamble Health Ltd — Financial Ratios & Key Metrics

₹4798.80

-1.61%

P/E Ratio31.44xIndustry: 31.77x

ROE36.42%Return on equity

ROCE47.75%Return on capital

Debt/Equity0.01Low debt

💎

Valuation & Profitability

P/E Ratio

31.44x

Industry Average P/E

31.77x

Dividend Yield

2.15%

Market Cap

₹9.65K (Cr)

Sales Growth 5Y

0.16%

Profit Growth 5Y

8.11%

EPS Growth 5Y

8.11%

OPM 5Y Avg

26.17%

📉

Price Returns

1 Month

-5.66%

3 Months

-8.13%

6 Months

+3.81%

1 Year

+12.37%

52W Low

₹4725

Current

₹4799

52W High

₹6739

4% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹5112

▼ Price below SMA 50 — Bearish

SMA 200

₹5779

▼ Long-term downtrend

Volume Signal

88% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Procter & Gamble Health Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.